Clinical trials: ICANS, Grade Unspecified
ICANS, Grade Unspecified, CAR T-Cell-Related Encephalopathy Syndrome
Multicenter Study Using IMC to Analyze the Impact of ICANS on Microglia
Immunotherapy with chimeric antigen receptor (CAR) T cell therapy can cause immune effector cell-associated neurotoxicity syndrome (ICANS). However, the molecular mechanisms leading to ICANS are not well understood.
- Trial name
- NCT05811117
- Testing
- There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
- Where
- Germany
- Volunteers
- 8 people
- Sponsor
- University of Freiburg